— A 40-Year-Old Woman with Postpartum Dyspnea and Hypoxemia — NEJM This article is available to subscribers. Sign in now if you're a subscriber. Access includes the full-text article, media, slides, and article PDF. ... New England Journal of Medicine, 6 days ago
Case 22-2014 — A 40-Year-Old Woman with Postpartum Dyspnea and Hypoxemia - New England Journal of Medicine, 6 days ago
A Woman with Postpartum Dyspnea and Hypoxemia - New England Journal of Medicine, 1 week ago
Living with chronic obstructive pulmonary disease (COPD) means finding ways to breathe easier, but shortness of breath dyspnea doesn't only affect your lungs.Shortness of breath can also make it difficult to eat, leading to another common ...BlackDoctor.org, 1 week ago
|New England Journal of Medicine, 3 weeks ago Case 9-2014: A 34-Year-Old Woman with Increasing Dyspnea New England Journal of Medicine, 1 month ago Erratum: Case 9-2014: A 34-Year-Old Woman with Increasing Dyspnea New England Journal of Medicine, 1 month ago An Uncommon Cause of Throat Pain Advance For NPs And PAs, 1 week ago|
A 29-year-old man presented with an acute onset of right pleuritic chest pain and a 3-month history of dyspnea, cough, and skin lesions. Physical examination revealed crackles in both lungs and multiple nonerythematous papules along the ink lines of ...New England Journal of Medicine, 1 month ago A Man in His 40s With Frequent Bronchitis, Localized Wheezes, and Hemoptysis CHEST, 1 month ago
By a News Reporter-Staff News Editor at Cardiovascular Week -- From Alexandria, Virginia , NewsRx journalists report that a patent by the inventors Hopper, Donald L . ( Maple Grove, MN ); Voegele, John ( Bethel, MN ); Hartley, Jesse W. ( Lake Elmo, ...HispanicBusiness.com, 1 month ago Patent Issued for Aminopyridine- and Aminopyrimidinecarboxamides as CXCR2 Modulators 4 Traders, 7 hours ago Patent Issued for Compounds and Methods for the Treatment of Pain and Other Diseases Pharmacy Choice, 1 week ago Patent Issued for Implantable Heart Monitoring Device and Method HispanicBusiness.com, 1 month ago
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials
Rennard SI, Sun SX, Tourkodimitris S, Rowe P, Goehring UM, Bredenbröker D, Calverley PM Authors: Rennard SI, Sun SX, Tourkodimitris S, Rowe P, Goehring UM, Bredenbröker D, Calverley PM Journal: DOI: Recommend publication Bookmark ...Bionity.com, 3 weeks ago
Section Sponsored by: Dyspnea, coughing, wheezing and chest tightness are well-known symptoms of asthma. Because of this, many patients are diagnosed with asthma based on symptoms alone. Sometimes patients are given a trial of medication and a ...Advance for Respiratory Care & Sleep Medicine, 3 weeks ago Asthma Assessment Advance for Respiratory Care & Sleep Medicine, 1 month ago
People with dyspnea, or shortness of breath, have an increased long-term mortality risk compared with individuals without dyspnea. This is according to a new study presented at the 2014 American Thoracic Society International Conference. "Dyspnea may be an ...Med India, 2 months ago
Findings in the Area of Multiple Myeloma Reported from Center for Drug Evaluation and Research (U.s. Food and Drug Administration approval:...
Findings in the Area of Multiple Myeloma Reported from Center for Drug Evaluation and Research (U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma) By a News Reporter-Staff News Editor at Medical Letter ...Pharmacy Choice, 5 hours ago U.S. Food and Drug Administration Approves Gilead's Zydelig® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma and Small Lymphocytic Lymphoma Industrial Info Financials, 15 hours ago Study Results from Department of Laboratory Medicine Provide New Insights into Chronic Lymphocytic Leukemia (Tumor lysis syndrome in a chronic... 4 Traders, 1 week ago FDA Approves Novo Nordisk A/S's NovoSeven® RT To Treat Glanzmann's Thrombasthenia (GT) With Refractoriness BioSpace, 2 weeks ago
(GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that the United Kingdom's National Institute of Health and Care Excellence (NICE) has published the technology appraisal ...BioSpace, 12 hours ago Sucampo Announces Publication of NICE Recommendation for AMITIZA (Lubiprostone) FirstWord Pharma, 21 hours ago Sucampo Pharmaceuticals : Announces Publication of NICE Recommendation for AMITIZA(R) (Lubiprostone) 4 Traders, 20 hours ago Swissmedic Approves AMITIZA(R) (Lubiprostone) for the Treatment of Opioid-Induced Constipation PredictWallStreet, 2 weeks ago
on your WebpageAdd Widget >Get your members hooked!